Search the Newsreel

Enterprise value to EBITDA forward of Prelude Therapeutics Incorporated – NASDAQ:PRLD

This article focuses on the enterprise value to EBITDA forward of Prelude Therapeutics Incorporated (NASDAQ: PRLD). It provides a brief financial overview for the company, indicating the market status and presenting the "Period Value Change Change %" without specific numerical values. The content highlights …

Prologis Raises Segro Bid to $18.2 Billion With 9.7% Premium

This article first appeared on GuruFocus. Prologis, a U.S. warehouse property giant, has increased its proposed takeover of Segro (SGRO), the UK's largest publicly traded property company and Europe's biggest logistics landlord, to 13.5 billion, or about $18.2 billion. The revised proposal, delivered on …

Enterprise value to revenue forward of Prelude Therapeutics Incorporated – NASDAQ:PRLD

This article provides financial context for Prelude Therapeutics Incorporated (NASDAQ: PRLD), focusing on its enterprise value to revenue forward metric. The information is presented within a market data and financial analysis platform, likely TradingView, indicating that the content is a snapshot of financial data …

Are You Looking for a Top Momentum Pick? Why Prologis (PLD) is a Great Choice

Momentum investing revolves around the idea of following a stock's recent trend in either direction. In "long context," investors will be essentially be "buying high, but hoping to sell even higher." With this methodology, taking advantage of trends in a stock's price is key; …

Segro rebuffs enhanced $18.2B Prologis takeover bid

Prologis said Monday that its enhanced bid to acquire London-based logistics warehouse operator Segro had been rejected. Prologis' third offer, valued at £13.5 billion ($18.2 billion), represented a 6% increase above its initial proposal and included a 20% cash component. The latest offer, a …

Segro rebuffs third approach from US bidder worth £13.5bn

Segro's US suitor has revealed a third takeover approach worth £13.5 billion has been rejected by the British warehouse property developer as it steps up its campaign to secure a deal. Prologis said it put forward a new cash-and-stock proposal to buy FTSE 100 …

Prelude Therapeutics Q1 2026 Earnings: EPS Surprises to the Upside but Stock Slips on Pipeline Uncertainty - Cash Flow Report

Prologis Submits Third Takeover Proposal For SEGRO

(RTTNews) - Prologis, Inc. (PLD), an industrial real estate investment trust, on Monday it submitted a third proposal to acquire all issued and to be issued share capital of SEGRO Plc (SGRO.L), increasing its offer and introducing a partial cash alternative after its previous …

Prologis Sets Record as Data Center Growth Boosts Results

This story was originally published on CRE Daily. Join 70,000+ commercial real estate professionals getting daily news, market insights, and industry analysis delivered straight to their inbox with the free CRE Daily newsletter. Key Takeaways Prologis posted a 12% jump in quarterly funds from …

Prelude Therapeutics Incorporated (NASDAQ:PRLD) Given Consensus Rating of "Hold" by Brokerages

Research Analysts Offer Predictions for PRLD Q2 Earnings

Prelude Therapeutics (PRLD) Upgraded to Buy: Here's Why

ProLogis, Inc.: Konsensus der Analysten und Kursziel | A1JBD1 | US74340W1036